Immunophenotyping

The term immunophenotyping refers to a range of flow cytometric technologies to quantify immune cell populations and their activation state by visualizing predefined marker proteins. The technologies are synergistic to the single-cell sequencing activities in the CCGA. Immunophenotyping is used, for example, to define molecular endpoints for clinical interventions. The exact description of multidimensional immunophenotypes and their correlation with patient-specific clinical data is an important component of precision medicine.

PHSH is committed to strengthening and harmonizing the technical infrastructure for immunophenotyping, for example through investment in cutting-edge equipment.